Cannabis

The three main species typically recognized within the Cannabis sativa L. family include Cannabis sativa, Cannabis indica and Cannabis ruderalis. The most well-known compounds found within the cannabis plant are THC, cannabidiol (CBD) and cannabinol (CBN).

CBD Oil: Health Benefits and Risks

There is a growing interest in CBD as a potential drug in the treatment of a wide spectrum of neurologic and neuropsychiatric disorders. However, caution must be taken.

Cannabis and Psychosis

Hemp Seed Oil Health Benefits

Does Smoking Cannabis Indoors Affect Children's Health?

Health Effects of Eating Cannabis (Marijuana)

Can Cannabis Use Alter Sperm DNA?

The Potential Advantages of Patient-Directed Cannabis Therapy

Does CBD Oil Work for Arthritis Pain?

Cannabis Use and Acute Myocardial Infarctions in Young People

Using a Portable Raman Spectrometer for Detection of THC

Synthesizing Cannabis from Yeast

Latest Cannabis News and Research

Researchers determine the effects of after-hours cannabis use on workplace performance

Although it has become increasingly accepted for medical and recreational use, cannabis is still considered among one of the most widely used illegal substances in the United States and in many European countries.

12 Aug 2020

Maternal cannabis use in pregnancy linked to increased risk of autism in children

In the largest study of its kind, Ottawa researchers found that children whose mothers reported using cannabis during pregnancy were at greater risk of autism.

10 Aug 2020

Will smoking cannabis harm your heart?, yes says AMA

The American Heart Association (AHA), in their statement, has said that smoking cannabis (marijuana) could be harmful to the heart. This new stand on smoking weed was published this week in the journal Circulation. The announcement is released as an article titled, “Medical Marijuana, Recreational Cannabis, and Cardiovascular Health: A Scientific Statement From the American Heart Association.”

6 Aug 2020

Cannabinoids may alter the effects of some prescription drugs

Cannabinoid-containing products may alter the effects of some prescription drugs, according to Penn State College of Medicine researchers.

3 Aug 2020

FDA approves CBD oral solution for treatment of seizures related to tuberous sclerosis complex

Today, the U.S. Food and Drug Administration approved Epidiolex (cannabidiol) [CBD] oral solution for the treatment of seizures associated with tuberous sclerosis complex (TSC) in patients one year of age and older.

31 Jul 2020

New program can help laboratories measure key chemical compounds in cannabis products

The National Institute of Standards and Technology (NIST) has launched a program to help laboratories accurately measure key chemical compounds in marijuana, hemp and other cannabis products including oils, edibles, tinctures and balms.

28 Jul 2020

Study: Stimulant use is higher in states without medical cannabis laws

Medical and non-medical prescription stimulant use is higher in states without medical cannabis laws (MCLs) than in states with MCLs among heterosexuals and among certain lesbian, gay and bisexual (LGB) subpopulations.

28 Jul 2020

SP Industries announces partnership agreement with Ecodyst to distribute single sample evaporation systems

SP Industries CEO Brian Larkin has announced the signing of a partnership agreement with Ecodyst.

From SP Scientific 24 Jul 2020

Cannabis could be a potentially effective treatment for sickle cell disease pain

Cannabis appears to be a safe and potentially effective treatment for the chronic pain that afflicts people with sickle cell disease, according to a new clinical trial co-led by University of California, Irvine researcher Kalpna Gupta and Dr. Donald Abrams of UC San Francisco. The findings appear in JAMA Network Open.

17 Jul 2020

CBD may help reduce cytokine storm and excessive lung inflammation in COVID-19

Cannabidiol, or CBD, may help reduce the cytokine storm and excessive lung inflammation that is killing many patients with COVID-19, researchers say.

16 Jul 2020

UHN leads first-of-its-kind real world evidence study of medical cannabis

Medical cannabis is finally being put under the microscope, in a first-of-its-kind real world evidence study led by Dr. Hance Clarke, Director of Pain Services, Toronto General Hospital, and a recognized leader in educating Canadians about chronic pain management and the risk factors of continued opioid use.

9 Jul 2020

BU researchers develop new method to better understand cell communication

Researchers from Boston University School of Medicine have developed and implemented a new way to better understand how human cells communicate with each other, how this communication is disrupted in human diseases and how this can be corrected pharmacologically.

6 Jul 2020

Cannabis offences in schools across England rise, data reveals

The number of offences for the possession of Cannabis, the possession of hard controlled drugs like Heroin, Cocaine and Ecstasy and drug trafficking in schools, colleges and Universities across England have all risen in the last few years, according to new insight by leading drug addiction experts UKAT.

3 Jul 2020

Study may help develop better treatment strategies for cannabis dependence

Researchers at Center for BrainHealth, part of The University of Texas at Dallas, recently examined underlying brain networks in long-term cannabis users to identify patterns of brain connectivity when the users crave or have a desire to consume cannabis.

2 Jul 2020